CTSdatabase and IRB Company Successfully Collaborate to Provide Expedited Review of Subject Registry Authorizations for Prescreening Sites

Share Article

In order to efficiently reduce the number of duplicate and professional subjects entering clinical trials, CTSdatabase and IRB Company have partnered to a deliver quick and inexpensive approval process for sites. Utilizing the CTSdatabase template Subject Database Authorization, IRB Company is able to expedite IRB approval for sites and support quality enrollment.

Over the last year, IRB Company (IRBCo.) of Buena Park, CA and CTSdatabase, LLC (CTS) of Beverly Hills, CA, have worked together to provide fast and inexpensive IRB approvals for over 40 sites using CTSdatabase to weed out duplicate and professional subjects during the prescreening process.

CTSdatabase provides the sites with a generic template and sites simply add their contact information and submit for expedited review to irb(at)irbco.com with the CV and license of the Principal Investigator. Within just a few business days, sites are provided with IRB-approved documents.

“We don’t want red tape to block the way of sites trying to do the right thing,” says Tom Shiovitz, M.D., President of CTSdatabase. “Preventing professional subjects, who may change their diagnosis, participate in multiple studies at once and pretend to take investigational medication, from entering studies, is good for everyone. It gives pharmaceutical companies a chance to bring promising medications to market and allows patients access to new treatments. At the same time, successful studies protect research subjects from unnecessary exposure to potential adverse events. Also, those professional subjects who do take multiple investigational medications at one time may be protected from very real risks to their health that could come from multiple study enrollments.”

“We support what CTSdatabase is doing to prevent duplicate enrollment,” says Anil Sharma, M.D., CEO and Medical Director of IRBCo. “Our streamlined, efficient approach to approval of generic prescreening consents like the CTSdatabase Subject Authorization, allows us to deliver faster and more inexpensively than our competitors.”

About CTSdatabase, LLC: CTSdatabase is a privately-owned company which provides clinical trial investigators and pharmaceutical companies with critical information on past (and concurrent) research participation by potential subjects. HIPAA-compliant and secure, the web-based system provides an immediate printout detailing when, where and for what indications a subject has previously participated in clinical trials, increasing the chances for successful study outcomes.

About IRB Company, Inc: IRBCo. is one of the oldest independent IRBs in the US, operating for over 34 years. IRBCo. is fully AAHRPP accredited and provides investigators, CRO’s and pharmaceutical sponsors with the highest quality of ethical reviews with quick turnaround times of 1-2 days for Expedited and 5-7 days for Full-Board reviews. IRBCo. utilizes an advanced and efficient web-based submission system that allows 24/7 tracking and access to study documents.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Thomas Shiovitz, M.D.
Visit website